Investigation Overview
October 17, 2014 (Update) - On September 17, 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) confirmed that it had received an unsolicited, non-binding proposal from Endo International plc (NASDAQ: ENDP) to acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) common stock at a price of$28.10 per share in cash and Endo International plc (NASDAQ: END) ...
You must register (for free) or login to view the entire investigation.